Alimentary Health Announces Additional Clinical Studies Evaluation Agreement with Procter & Gamble
Alimentary Health is a leader in pioneering the development of safe and effective therapeutics for GI and other indications. AH probiotic technology such as Bifantis® (Bifidobacterium infantis 35624), has been clinically proven to manage a full range of episodic digestive upsets, including constipation, diarrhea, abdominal discomfort, urgency, gas and bloating. Bifantis is only found in the daily probiotic supplement Align® which is being marketed by P&G in the US under a current licensing agreement with AH. This new Clinical Studies Agreement is designed to further explore the clinical benefits of AH technology over the next several years.